Login / Signup

Hepatocellular Carcinoma Risk Scores Predict Patients Under Surveillance at Low Risk of Benefit and High Risk of Harm.

Christopher CurranMatthew PriestShouren DattaEwan H ForrestAdrian J StanleyStephen T Barclay
Published in: Digestive diseases and sciences (2022)
This was not a clinical trial and the study was not pre-registered.
Keyphrases
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • public health
  • prognostic factors
  • randomized controlled trial
  • open label
  • study protocol
  • phase ii
  • double blind
  • patient reported
  • breast cancer risk